Evidence map›Paper›PMID 29317497›Full record

ArticleThe Journal of biological chemistry2018

Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways.

Kathleen E Tumelty, Nathan Higginson-Scott, Xueping Fan, Piyush Bajaj, Kelly M Knowlton, Michael Shamashkin, Anthony J Coyle, Weining Lu, Stephen P Berasi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. GREM1 signaling in cancer: tumor promotor and suppressor?Journal of cell communication and signaling · 2023
    Article
  4. Article
  5. Article
  6. SMAD4 Feedback Activates the Canonical TGF-β Family Signaling Pathways.International journal of molecular sciences · 2021
    Article
  7. Control of ovarian follicle development by TGFβ family signaling.Current opinion in endocrine and metabolic research · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in medicine · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Kathleen E TumeltyFrom the Centers for Therapeutic Innovation, Pfizer Inc., Cambridge, Massachusetts 02139.
Nathan Higginson-ScottFrom the Centers for Therapeutic Innovation, Pfizer Inc., Cambridge, Massachusetts 02139.
Xueping Fanthe Renal Section, Department of Medicine, Boston University Medical Center, Boston, Massachusetts 02118, and.
Piyush Bajajthe Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.
Kelly M KnowltonFrom the Centers for Therapeutic Innovation, Pfizer Inc., Cambridge, Massachusetts 02139.
Michael ShamashkinFrom the Centers for Therapeutic Innovation, Pfizer Inc., Cambridge, Massachusetts 02139.
Anthony J CoyleFrom the Centers for Therapeutic Innovation, Pfizer Inc., Cambridge, Massachusetts 02139.
Weining Luthe Renal Section, Department of Medicine, Boston University Medical Center, Boston, Massachusetts 02118, and.
Stephen P BerasiFrom the Centers for Therapeutic Innovation, Pfizer Inc., Cambridge, Massachusetts 02139, stephen.berasi@pfizer.com.
Pfizer (United States) · USCenters for New Horizons · USBoston Medical Center · USUniversity Medical Center · US

Funding

Molecular Pathogenesis of Vesicoureteral RefluxR01DK078226 · NIDDK · BOSTON MEDICAL CENTER · PI LU, WEINING · 2008 to 2018
$2.5M
NIDDK NIH HHS R01 DK078226
6 · The paper itself

Abstract

Slit guidance ligand 2 (SLIT2) is a large, secreted protein that binds roundabout (ROBO) receptors on multiple cell types, including neurons and kidney podocytes. SLIT2-ROBO-mediated signaling regulates neuronal migration and ureteric bud (UB) outgrowth during kidney development as well as glomerular filtration in adult kidneys. Additionally, SLIT2 binds Gremlin, an antagonist of bone morphogenetic proteins (BMPs), and BMP-Gremlin signaling also regulates UB formation. However, direct cross-talk between the ROBO2-SLIT2 and BMP-Gremlin signaling pathways has not been established. Here, we report the discovery of negative feedback between the SLIT2 and BMP-Gremlin signaling pathways. We found that the SLIT2-Gremlin interaction inhibited both SLIT2-ROBO2 signaling in neurons and Gremlin antagonism of BMP activity in myoblasts and fibroblasts. Furthermore, BMP2 down-regulated SLIT2 expression and promoter activity through canonical BMP signaling. Gremlin treatment, BMP receptor inhibition, and SMAD family member 4 (SMAD4) knockdown rescued BMP-mediated repression of SLIT2. BMP2 treatment of nephron progenitor cells derived from human embryonic stem cells decreased SLIT2 expression, further suggesting an interaction between the BMP2-Gremlin and SLIT2 pathways in human kidney cells. In conclusion, our study has revealed direct negative cross-talk between two pathways, previously thought to be unassociated, that may regulate both kidney development and adult tissue maintenance.

Indexed as

Signal TransductionBone Morphogenetic Protein 2Cell MovementDown-RegulationFeedback, PhysiologicalHEK293 CellsHumansIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsNeuronsPromoter Regions, GeneticProtein DomainsSlit Homolog 2 ProteinBone Morphogenetic Protein 2GREM1 protein, humanIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsSlit Homolog 2 Proteinbone morphogenetic protein (BMP)developmentfibrosisGremlinkidneyprotein–protein interactionROBO2SLIT2transcription regulation

Identifiers

PMID29317497
PMCPMC5836125
OpenAlexW2782847036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.